1. Home
  2. AVDL vs AVAH Comparison

AVDL vs AVAH Comparison

Compare AVDL & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.69

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$7.85

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
AVAH
Founded
2015
1984
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
AVDL
AVAH
Price
$21.69
$7.85
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
$19.14
$10.56
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
03-02-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.37
Revenue
$248,517,000.00
$2,290,591,000.00
Revenue This Year
$65.47
$21.81
Revenue Next Year
$30.88
$5.96
P/E Ratio
N/A
$20.95
Revenue Growth
79.88
15.48
52 Week Low
$6.38
$3.67
52 Week High
$23.57
$10.32

Technical Indicators

Market Signals
Indicator
AVDL
AVAH
Relative Strength Index (RSI) 63.88 38.60
Support Level $21.52 $7.68
Resistance Level $21.69 $8.63
Average True Range (ATR) 0.06 0.38
MACD -0.01 -0.10
Stochastic Oscillator 66.67 10.98

Price Performance

Historical Comparison
AVDL
AVAH

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: